IKT - Balance Sheet - Inhibikase Therapeutics, Inc.

Current Liabilities	3.73 M
Accounts Payable	943 K
Short-Term Debt	111 K
Other Current Liabilities	2.68 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	56.5	9.2	7.2	40.8	14.0	18.5 K	0.4	16.7 K	12 K
Short Term Investments	41.1	4.1	15.9	0	0	0	0	0	0
Receivables	0	0	39.9 K	0.1	0	0	0.5	0.2	66.9 K
Inventory	0	0	1.1	0.1	0	0	0	0	0
Other Current Assets	0.8	1.0	1.3	1.6	0.8	16.9 K	0.4	625	1.25 K
Total Current Assets	98.5	14.2	24.4	42.5	14.8	35.4 K	1.3	0.2	80.2 K
PP&E	0.1	0.3	0.6	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	(15.8)	0	0	0	0	87.1 K	0
Other Long Term Assets	47.1 K	0	15.8	0	0	2.87 K	1.6	0	82.8 K
Other Assets	0	0	0	1.6	0.8	0	0	0	0
Total Assets	98.6	14.5	24.9	42.5	14.8	38.3 K	2.8	0.3	0.2
LIABILITIES
Accounts Payable	0.9	0.6	1.2	1.1	1.7	1.0	1.0	0.4	0.4
Short Term Debt	0.1	0.5	0.3	0.2	42.5 K	98.4 K	0.2	0.5	0.3
Other Current Liabilities	2.7	2.3	2.3	2.7	0.6	1.7	2.2	0.9	0.8
Total Current Liabilities	3.7	3.4	3.7	4.1	4.7	4.3	3.6	1.7	1.5
Long Term Debt	0	90.1 K	0.2	0	0.3	0.3	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	0	0	0
Total Liabilities	3.7	3.5	3.9	4.1	5.0	4.5	3.6	1.7	1.5
EQUITY
Common Stock	69.4 K	6.19 K	25.2 K	25.2 K	10.1 K	8.18 K	8.18 K	8.92 K	8.92 K
Retained Earnings	(94.4)	(66.9)	(47.9)	(29.8)	(15.0)	(12.2)	(6.5)	(4.3)	(3.9)
Other Accumulative Comprehensive Income/Loss	37.2 K	877	0.1	0	0	0	0	0	0
Total Equity	94.9	11.0	21.0	38.4	9.8	(4.5)	(0.8)	(1.4)	(1.4)
Total Liabilities and Equity	98.6	14.5	24.9	42.5	14.8	38.3 K	2.8	0.3	0.2
SHARES OUTSTANDING
Common Shares Outstanding	23.7	5.3	4.2	3.0	1.7	1.7	1.3	1.7	1.3

Free